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Abstract
Background: Recurrent spontaneous abortion (RSA) often remains unclear and can
be burden for the patient and time consuming for clinician. RSA may initiates from a
genetic or non-genetic factors. It is well known that the quality of placental circulation
is critical for implantation and embryo development. Because of angiogenic effects
of VEGF–KDR pathway on placenta, the genes involved in this pathway (the KDR or
VEGFR genes) are thought to be linked with RSA.
Objective: The aim of this study was to investigate the relationship between Gln472His
(A/T) polymorphism of the KDR gene with RSAs in southern Iran.
Materials and Methods: In this case-control study, 50 aborted embryonic tissue
obtained from fetuses and 50 umbilical cord blood of newborn babies were studied.
Fetal sample from mothers with history of at least two consecutive miscarriages and
controls from mothers who had at least one full-term infants born were taken. Genomic
DNA was extracted by using PureLink genomic DNA kit (Life Technologies, CA). The
Rotor-Gene Q real-Time PCR machine and High-resolution melting curve analysis
(HRM) technique were used for genotyping.
Results: Based on the AA genotype as reference, it is shown that the T allele (OR =
2.447, 95% CI = 1.095–5.468, p = 0.029) as well as AT heterozygote genotype was
significantly associated with an increased risk of miscarriage (OR = 2.824, 95% CI =
1.210-6.673, p = 0.016).
Conclusion: A positive correlation between Q472H polymorphism of the KDR gene
and RSA may be the cause in southern Iran.
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1. Introduction
Three or more consecutive pregnancy losses
before the 20th wk of gestation is referred to
as recurrent spontaneous abortion (RSA) (1). This
is a reproductive issue that challenges approx-
imately 1% of women at the reproductive age,
and the causes of about half of the RSA cases
remain undecided (2-4). Chromosomal abnormal-
ities are one of the main causes of spontaneous
abortion (5) followed by molecular genetic defect
like inherited thrombophilia. Non-genetic causes
including abnormalities of the uterus, dysfunctions
of the endocrine system, autoimmune diseases,
as well as nutritional and environmental parame-
ters are also mentioned on the etiology of RSA
(6, 7). Vascular endothelial growth factor (VEGF)
as a main angiogenic factor has a primary role
in the regulation of endothelial cell proliferation.
It also acts as a survival factor for endothe-
lial cells during both physiological and tumor
angiogenesis. Furthermore, VEGF is a vasodilator
that increases vascular permeability and has anti-
apoptosis properties (8, 9). VEGF is a critical
factor in the early stages of pregnancy such as
oocyte maturation and the growth of trophoblast.
It is also important in the implantation and sub-
sequent development of the embryo. Moreover,
the angiogenesis during placenta development
as well as the formation of maternal and fetal
blood vessels in the uterus is related to VEGF
(10, 11). There are two tyrosine kinase receptors
for VEGF, VEGF receptor 1 (VEGFR1/FLT1) and
VEGF receptor 2 (VEGFR2/FLK1/KDR) (12). These
two VEGF receptors -a signal-transducing receptor-
carries Kinase domain, which has also been stated
to be associated with RSA in report, possibly
resulting from the effects on the angiogenesis
of placenta via the VEGF-KDR pathway (11, 13,
14). Placental angiogenesis is important for the
successful development of a fetus considering
the influences on the transplacental exchange
between maternal and fetal blood flow (15). In
human during the early pregnancy, the KDR gene
expresses has critical roles on normal physiology
or physiopathology of placental precursor cells.
It has influence on the vasculogenic as well as
angiogenic of proliferative endothelial cells and
altered quality of its migration as well (16, 17).
Experimentally in the KDR gene knockout, mice
embryonic death occurs due to defects in the
fetal and placental vasculogenesis and angiogen-
esis (18). A number of single nucleotide poly-
morphisms (SNPs) in the KDR gene have been
reported that have effect on the pathogenicity of
several diseases including RSA, lung and breast
cancers, coronary heart disease, as well as cere-
brovascular disorder (19). These SNPs include –
604T/C at the KDR promoter region alternate/affect
promoter activity, 1192G/A (rs2305948) in exon
7 with the Val297Ile substitution, and 1719A/T
(rs1870377) in exon 11 with the Gln472His substitu-
tion effects on the function of VEGF/KDR pathway
(20, 21).
In Iran, there are at least two studies regarding
the KDR gene polymorphism and RSA (22, 23).
These reports have been done on the mother’s
blood and the effect of paternal imprint is mis-
treated. In this study, the 1719A/T in the exon 11 of
KDR gene of fetal as a risk factor for RSA in our area
has been analyzed.
2. Materials and Methods
2.1. Subjects
In total, 50 samples of embryonic tissue
(obtained from fetuses) and 50 umbilical cord
blood of newborn babies were selected randomly
from the Shiraz Hafez Hospital ( Jan-May 2017). The
fetus selected from mothers who had experienced
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at least two consecutive miscarriages earlier and
controls from mothers had at least one full-term
infants. These groups Maternal control group and
cases group were matched by ethnicity and age.
All subjects with underlying diseases or abnormal
laboratory data including immunologic, infection,
or abnormal karyotype were excluded from the
controls.
2.2. Genetic analysis
Genomic DNA from embryonic tissue as well as
whole EDTA blood was extracted using PureLink
genomic DNA kit (Life Technologies, CA) according
to the manufacturer instructions. The quantity and
quality of extracted DNA were checked by Nan-
odrop spectrophotometer (BioTek company) and
0.8% agarose gel electrophoresis, respectively. All
DNA samples were stored at -20°C until further
analysis. Genetic variations for Gln472His (A/T)
SNP was analyzed by LC-Green (Idaho Technology,
Salt Lake City, Utah, USA) high-resolution melting
(HRM) curve method following the PCR amplifica-
tion (Qiagen company).
2.3. Primers sequences






2.4. PCR reactions and melting analy-
sis
PCR was performed in 8 μl volum with 20 ng of
template DNA, 1.5 mM MgCl2, 265 μM dNTP, 10
pico mol of forward and reverse primers, and 0.8X
LC-Green Plus (Idaho Technology, Salt Lake City,
Utah, USA). Platinum Taq Polymerase (Invitrogen,
Paisley, Scotland) is used for PCR.
PCR cycling conditions included an initial acti-
vation step at 95°C for 5 min followed by 40
cycles of denaturation for 10 s at 95°C and
annealing/extension step for 30 s at 55°C to allow
for fluorescence data acquisition on the green
channel. A 192 bp PCR product is accomplished
by HRM analysis in the range of 65-95°C and 0.1°C
rising at each cycle. All test run with null template
control (NTC) and control of known genotype
on each course. A Sanger sequence confirmed
sample is used as control in HRM-Realtime PCR
and 20 samples (case and control) were ran-
domly selected and checked by sequencing for re-
conformation.
2.5. Ethical consideration
The research was performed whit the approval
of the Ethics Committee of the Islamic Azad
University, Dehaghan Branch (Approval No.
IR.IAU.DEHAGAN.REC.1397.002), a written consent
was obtained from all the mother whose fetuses or
cord bloods were used.
2.6. Statistical analysis
Statistical analysis performed by using SPSS
software version 18.0 statistical program (Statisti-
cal Package for the Social Sciences, SPSS Inc.,
Chicago, Illinois, USA). Chi-square test and logistic
regression analysis were used to analyze the differ-
ences between the abortion materials and control
subjects. Corresponding genotype and allele fre-
quencies between fetal cases and control group is
compered. For the risk assessment of the KDR SNP,
Odds ratio (OR) and p-values were used.
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3. Results
Real-time PCR and Melting Analysis technique,
Gln472His (A/T) polymorphism of the KDR gene
were evaluated in study groups (50 abortion
materials and 50 control subjects) (Figure 1), and
the results were compared between both the
fetus and control groups. The mean age of the
mothers of case group was 32.07 ± 4.23 yr, and
the mean age of the mothers of controls was
33.49 ± 3.80 yr. The other diseases that may
contribute with pregnancy outcome exclude in
the study groups. Demographic characteristics and
clinical profiles of RSA patients and controls are
summarized in Table I for comparison. For the
controls and RSA patients, genotype and allele
frequencies of polymorphism KDR Gln472His (A/T)
are listed in Table II. All genotype distributions
among the study patients were in Hardy–Weinberg
equilibrium. In the statistical analysis, AT genotype
and T-allele in dominance were found as risk
factors for abortion in case group. AT genotype
represents and T-allele in dominance represents
2.824 and 2.447-fold risk reactively in fetus group
compared with the control group. The difference in
genotypes frequencies between fetus and control
group was not statistically significant (p > 0.05)
(Table II).
Table I. Demographic data of cases and controls
Characteristic Case group (n = 50) Control group (n = 50) p-value*
Range of mother age 26–39 25-38 –
Average of mother age 32.77 ± 4.32 32.59 ± 3.89 0.942
Average of fetus age, mean wk ± SD 12.05 ± 3.2 – –
Average age of infants born, mean wk ± SD – 38.54 ± 1.16 –
Range number of abortions 2-4 – –
Average number of abortions 3.05 ± 1.64 – –
Note: Data are mean ± SD unless otherwise specified
*P-value by Fisher’s exact test; otherwise by χ2-test
Table II. Genotype frequencies of Gln472His polymorphism of the KDR gene among controls and RSA patients































AT + TT (T+) 20 (40%) 31 (62%) 0.029 2.447 1.095-468
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Figure 1. HRM profiles of the product 10–192 bp of the KDR Gln472His polymorphism.
4. Discussion
Far province is inhabitancy of multi-ethnic group
with distinct genetic property. Genetic variance
play a crucial role on the cause of morbidity and
mortality of fetus.
The implantation of the embryo is a vital stage
in reproduction. It requires an appropriate com-
munication between the mother as a receptive
endometrium and the embryo. Various factors
affect endometrium which can be summarized
as follows various cytokines, growth factors, and
adhesion molecules (24-26). Among these factors,
VEGF and its receptors, VEGF receptor 1 (VEGFR1/
Flt1) and VEGF receptor 2 (VEGFR2/Flk1/KDR) have
a very important role in the formation of the car-
diovascular system (27). Other investigations have
also reported that disturbances in the vascular
formation and function might be the contributing
factor in several female reproductive disorders, for
example, recurrent miscarriage and implantation
failure (12, 28, 29). The necessity of angiogene-
sis in a successful pregnancy and RSA through
VEGF and one of its receptors, KDR, has been
proposed in multiple studies (11, 15, 30, 31). A
report from Iran show that Q472H (rs1870377)
was highly linked to intronic SNP (rs6838752)
(23). We surveyed whether KDR polymorphisms,
including the Gln472His (A/T) SNP is a risk factor
for RSA in southern Iran. The aim of this study was
to evaluate KDR polymorphisms that have been
previously studied for the association with RSA
risk. Our findings reveal that the KDR Gln472His
(A/T) polymorphism is consistently associated with
increased RSA risk and the allele A as the reference
allele shows significant differences between the
case and control samples (p = 0.016). Present
data are in agreement with association of Q472H
and A-C-A-T-G haplotype in the KDR gene with
susceptibility to miscarriage (11). Binding of VEGF
to KDR triggers multiple downstream signaling
cascades, including PI3 kinase-Akt, protein kinase
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C, mitogen-activated protein kinases, and eNOS
pathways, and induce migration and proliferation
of endothelial cells. Consequently, this stimulation
proceeds angiogenesis (32). It is believed that the
mentioned polymorphisms altered the biological
activity of corresponded pathway (21, 33, 34). The
position of Q472H polymorphism, regarding the
phenotypic condition in the favor of the dominance
of the T allele and this allele increases the risk of
abortion by 2.4 times. The Q472H SNP (rs1870377),
is located in the exon 11 and covers the fifth N-
terminal Ig-like domains within the extracellular
region. The extracellular domain is essential for
ligand binding. The substituted amino acid at
the codon 472 reduc VEGF-binding efficiency of
tyrosine receptor (KDR) (21). During embryonic
development, the KDR expression is restricted to
endothelial cells and encoded protein has a crucial
role on endothelial growth. precursors. Studies in
KDR knockout mice shows its vital roles in the
developing of blood vessel networks (14, 18, 35).
Also it is shown, this substitution of Glutamine
by Histidine increases VEGFR-2 protein phospho-
rylation thereafter micro vessel density increases
among lung cancer cases (36).
However there some reports that contraindicate
with this finding like study by Rah et al. who did
not find the KDR polymorphism susceptibility to
RSA in Taiwanese as wel as Korean cases. (20, 37).
Contradictory results between two Asiatic ethnic
groups, may arise from various factors, including
a different definition of patients and controls for
each study and ethnic variation or a combination of
them. However, the limited sample size in this study
may be required to replicate with a larger sample
size. Finemapping of specific loci within VEGF/KDR
and extra genic variants will be the future direction
and will provide more information on the functional
SNPs in these two genes.
5. Conclusion
There is a significant correlation between
Q472H polymorphism and related polymorphism
in the KDR gene with the risk of RSA and it should
take into account the RSA cases in the south of
Iran.
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